Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Industry sector: Medical
Sector classification: Surgical & medical instruments
Deep Learning based analysis and prediction model for Stryker Corporation (SYK) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.
Model is in the production pipeline since Sept. 19, 2017.
Market data for SYK model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for SYK.
Model is being retrained on a regular basis.
|% Held by Insiders||7.40%|
|% Held by Institutions||75.62%|
|EPS (last reported FY)||$6.49|
|EPS (last reported Q)||$1.68|
|EPS, estimated (last reported Q)||$1.60|
|Total revenues||$12 B|
|Net income||$1 B|